EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Patient Version of Guideline for Fibromyalgia (2025 Edition)

Zhiling Zhang, Pengxiang Zhou, Na He, Ziyang Wu, Shining Bo, Chao Chen, Shuhong Chi, Ning Hou, Ji Hu, Fanbo Jing, Baohua Li, Ling Li und 27 weitere

Journal of Evidence-Based Medicine · 2025

DOI: 10.1111/jebm.70094 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Evidence-Based Medicine, 2025. Verfasst von Zhiling Zhang und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Fibromyalgia, Practice Guidelines as Topic. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Society for Drug Regulation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To develop an evidence‐based patient version of guideline (PVG) for fibromyalgia, aiming to improve patients’ understanding of disease symptoms and therapeutic options and to enhance their self‐management abilities.

Methods

Following the World Health Organization Handbook for Guideline Development (2014), a multidisciplinary working group was established, including patient representatives, physicians, pharmacists, nurses, and methodologists. The process comprised (a) systematic retrieval of clinical practice guidelines and expert consensus statements to establish the evidence base; (b) integration of large language models (LLMs) with expert review to identify and refine key patient‐centered concerns; (c) a three‐round Delphi consensus guided by the Grading of Recommendations Assessment, Development and Evaluation approach to finalize clinical questions and formulate recommendations; and (d) evaluation of understandability using the Patient Education Materials Assessment Tool for Print Materials (PEMAT‐P).

Results

The final PVG covers 13 clinical questions across seven domains, including disease awareness, diagnostic evaluation, pharmacological and non‐pharmacological interventions, and long‐term management. All recommendations were rated as strong. The guideline emphasizes the importance of pharmacological management, emotional regulation, and exercise in the comprehensive management of fibromyalgia. The PEMAT‐P assessment showed an understandability score of 100%.

Conclusions

Developed collaboratively by a multidisciplinary team and patient representatives, this PVG is based on 13 evidence‐based fibromyalgia guidelines. Combining LLMs with expert review enhanced question generation and readability. The PVG provides a practical and accessible tool to support early self‐management in fibromyalgia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibromyalgiaPractice Guidelines as TopicHumansDelphi TechniquePatient Education as TopicEvidence-Based MedicineConsensus

Stichwörter der Autor:innen

Development and Evaluation (GRADE)Grading of Recommendations Assessmentfibromyalgialarge language modelspatient version of guideline

Autor:innen und Institutionen

  • Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Department of Critical Care Medicine, Peking University Third Hospital, Beijing, China.
  • Department of Pharmacy, The Sixth Medical Centre, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Department of Rheumatology and Immunology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.

Förderung

  • China Society for Drug Regulation
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Z., Zhou, P., He, N., Wu, Z., Bo, S., Chen, C., Chi, S., Hou, N., Hu, J., Jing, F., Li, B., Li, L., Li, S., Li, Y., Lin, Y., Luo, Q., Mai, J., Mu, R., Ouyang, R., …, & Zhai, S. (2025). Patient Version of Guideline for Fibromyalgia (2025 Edition). Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.70094

Vancouver

Zhang Z, Zhou P, He N, Wu Z, Bo S, Chen C, et al. Patient Version of Guideline for Fibromyalgia (2025 Edition). Journal of Evidence-Based Medicine. 2025. doi:10.1111/jebm.70094

BibTeX
@article{Zhang2025,
  author = {Zhang, Zhiling and Zhou, Pengxiang and He, Na and Wu, Ziyang and Bo, Shining and Chen, Chao and Chi, Shuhong and Hou, Ning and Hu, Ji and Jing, Fanbo and Li, Baohua and Li, Ling and Li, Shuiqing and Li, Yanni and Lin, Yang and Luo, Qipeng and Mai, Jiahui and Mu, Rong and Ouyang, Ronghui and Qin, Wangjun and Shao, Rong and Shen, Jianghua and Sun, Xiaoying and Wang, Tianlin and Wu, Junyan and Xie, Han and Xu, Xiaoyan and Yan, Yingying and Yang, Kehu and Yao, Zhongqiang and Ye, Chaoqun and Yuan, Yonggui and Zhu, Jintao and Zhao, Rongsheng and Zhang, Daying and Liang, Dongfeng and Zeng, Xiaofeng and Fan, Bifa and Zhai, Suodi},
  title = {Patient Version of Guideline for Fibromyalgia (2025 Edition)},
  journal = {Journal of Evidence-Based Medicine},
  year = {2025},
  doi = {10.1111/jebm.70094}
}
Kostenlos starten →